GlassScriptPhysician profile
Ramesh Kolli
NPI 1952510091
$716.46
in general payments reported to CMS, 2019-2025
10 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $65.27 · 2021: $85.62 · 2022: $125 · 2023: $143 · 2024: $21.83 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $310.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $146.60 | 2025 | Ensite |
| Inari Medical, INC. | $142.50 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2022 | |
| Boston Scientific Corporation | $85.62 | 2021 | |
| Janssen Pharmaceuticals, INC | $60.42 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $57.98 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $37.56 | 2019 | |
| Fisher & Paykel Healthcare INC | $22.94 | 2019 | |
| Pfizer INC. | $21.83 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $16.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramesh Kolli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.